( en | de | ru )

 

Disambiguierung von "Lohse, M. J."

Autor der Publikation

KopierenLöschenDiese Publikation zur Ablage hinzufügen
Beta-adrenoceptor polymorphisms and heart failure

. Trends Mol Med, 10 (2): 55-8 (Februar 2004)Lohse, Martin J Review England Trends in molecular medicine Trends Mol Med. 2004 Feb;10(2):55-8..

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

J J M Ramakers

J M Zöllner

J A M Wanders

Gabriele J M Demetz

Owen J M Kalinga

 

Weitere Publikationen von Autoren mit dem selben Namen

Cell type-specific regulation of beta2-adrenoceptor mRNA by agonists, und . Eur J Pharmacol, 331 (1): 73-8 (Juli 1997)Danner, S Lohse, M J Comparative Study Research Support, Non-U.S. Gov't Netherlands European journal of pharmacology Eur J Pharmacol. 1997 Jul 16;331(1):73-8..Synthetic peptides of the hamster beta 2-adrenoceptor as substrates and inhibitors of the beta-adrenoceptor kinase, , , , , , und . Br J Clin Pharmacol, (1990)Benovic, J L Onorato, J Lohse, M J Dohlman, H G Staniszewski, C Caron, M G Lefkowitz, R J England British journal of clinical pharmacology Br J Clin Pharmacol. 1990;30 Suppl 1:3S-12S..Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure, , , und . J Am Coll Cardiol, 27 (1): 146-54 (Januar 1996)Engelhardt, S Bohm, M Erdmann, E Lohse, M J Research Support, Non-U.S. Gov't United states Journal of the American College of Cardiology J Am Coll Cardiol. 1996 Jan;27(1):146-54..Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor, , , , , , , , , und . Circulation, 104 (21): 2602-7 (November 2001)Brede, M Hadamek, K Meinel, L Wiesmann, F Peters, J Engelhardt, S Simm, A Haase, A Lohse, M J Hein, L In Vitro Research Support, Non-U.S. Gov't United States Circulation Circulation. 2001 Nov 20;104(21):2602-7..Effects of phosducin on the GTPase cycle of Go, und . Naunyn Schmiedebergs Arch Pharmacol, 357 (4): 371-7 (April 1998)Bauer, P H Lohse, M J Comparative Study Research Support, Non-U.S. Gov't Germany Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1998 Apr;357(4):371-7..Phosducin, potential role in modulation of olfactory signaling, , , , , , und . J Biol Chem, 272 (7): 4606-12 (Februar 1997)Boekhoff, I Touhara, K Danner, S Inglese, J Lohse, M J Breer, H Lefkowitz, R J HL16037/HL/NHLBI NIH HHS/United States Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. United states The Journal of biological chemistry J Biol Chem. 1997 Feb 14;272(7):4606-12..Differential distribution of beta-adrenergic receptor subtypes in blood vessels of knockout mice lacking beta(1)- or beta(2)-adrenergic receptors, , , , , und . Mol Pharmacol, 60 (5): 955-62 (November 2001)Chruscinski, A Brede, M E Meinel, L Lohse, M J Kobilka, B K Hein, L Research Support, Non-U.S. Gov't United States Molecular pharmacology Mol Pharmacol. 2001 Nov;60(5):955-62..Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study, , , , , , , , , und 3 andere Autor(en). Eur J Heart Fail, 12 (7): 753-62 (Juli 2010)Deubner, Nikolas Berliner, Dominik Schlipp, Angela Gelbrich, Gotz Caforio, Alida L P Felix, Stephan B Fu, Michael Katus, Hugo Angermann, Christiane E Lohse, Martin J Ertl, Georg Stork, Stefan Jahns, Roland Etiology, Titre-Course, and Survival-Study Group Research Support, Non-U.S. Gov't Netherlands European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology Eur J Heart Fail. 2010 Jul;12(7):753-62. Epub 2010 May 21..Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice, , , und . Mol Pharmacol, 60 (4): 712-7 (Oktober 2001)Engelhardt, S Grimmer, Y Fan, G H Lohse, M J Research Support, Non-U.S. Gov't United States Molecular pharmacology Mol Pharmacol. 2001 Oct;60(4):712-7..Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice, , , , , , , , , und 15 andere Autor(en). J Clin Invest, 119 (12): 3597-3612 (Dezember 2009)Beetz, Nadine Harrison, Michael D Brede, Marc Zong, Xiangang Urbanski, Michal J Sietmann, Anika Kaufling, Jennifer Barrot, Michel Seeliger, Mathias W Vieira-Coelho, Maria Augusta Hamet, Pavel Gaudet, Daniel Seda, Ondrej Tremblay, Johanne Kotchen, Theodore A Kaldunski, Mary Nusing, Rolf Szabo, Bela Jacob, Howard J Cowley, Allen W Jr Biel, Martin Stoll, Monika Lohse, Martin J Broeckel, Ulrich Hein, Lutz HL082798/HL/NHLBI NIH HHS/United States In Vitro Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't United States The Journal of clinical investigation J Clin Invest. 2009 Dec;119(12):3597-3612..